GM Watch
  • Main Menu
    • Home
    • News
      • Newsletter subscription
      • News Reviews
      • News Languages
        • Notícias em Português
        • Nieuws in het Nederlands
        • Nachrichten in Deutsch
      • Archive
    • Resources
      • GM Myth Makers
      • Non-GM successes
      • GM Quotes
      • GM Myths
      • GM Firms
        • Monsanto: a history
        • Monsanto: resources
        • Bayer: a history
        • Bayer: resources
      • GM Booklet
      • GM Book
    • Contact
    • About
    • Donations
News and comment on genetically modified foods and their associated pesticides    
  • News
    • Newsletter subscription
    • News Reviews
    • News Languages
      • Notícias em Português
      • Nieuws in het Nederlands
      • Nachrichten in Deutsch
    • Archive
  • Resources
    • Non-GM Successes
    • GM Myth Makers
    • GM Quotes
    • GM Myths
    • GM Firms
      • Monsanto: a history
      • Monsanto: resources
      • Bayer: a history
      • Bayer: resources
    • GM Booklet
    • GM Book
  • Donations
  • Contact
  • About

INTRODUCTION TO GM

GMO Myths and Facts front page.jpg

GENE EDITING MYTHS, RISKS, & RESOURCES

Gene Editing Myths and Reality

CITIZENS’ GUIDE TO GM

GMO Myths and Truths front cover

PLEASE SUPPORT GMWATCH

Donations

If you like what we do, please help us do more. You can donate via Paypal or credit/debit card. Some of you have opted to give a regular donation. We greatly appreciate that as it helps place us on a more stable financial basis. Thank you for your support!

Bayer purchased Monsanto with European taxpayers’ money

Details
Published: 25 June 2019
Twitter

Bayer Window Logo

As Bayer’s situation worsens, taxpayers could take a big hit

According to an article in the German press by the journalist and author Gaby Weber, Germany’s central bank – the Bundesbank – helped finance Bayer’s takeover of Monsanto with European taxpayers’ money.

Three years ago, Bayer CEO Werner Baumann launched his bid to buy Monsanto. He promised it would make Bayer a global player and provide huge dividends for shareholders. According to Weber, greed prevented a prudent risk analysis. As a result, says Weber, Bayer’s stock is now in the doldrums, there are astronomical claims for damages coming from the US, and Bayer is threatened with takeover or bankruptcy.

Unfortunately, the buck stops not with Bayer’s shareholders or its managers, says Weber, but with the taxpayer. In the face of impending bankruptcy, the German government will probably step in – as it did in the banking crisis. The Bundesbank will also incur considerable losses in such a situation because it was the Bundesbank that financed a large part of the purchase of Monsanto, via a programme of the European Central Bank (ECB), which gets its money from European taxpayers.

A spokesman for the ECB, William Lelieveldt, has confirmed to Weber that the Bayer bonds were purchased under the ECB’s asset purchasing programme. But Weber says Lelieveldt wouldn’t disclose the exact amount or the interest rate.

Weber says Lelieveldt claimed that "risk management considerations" were employed. But Lelieveldt did not spell out what exactly these were. The bonds are in the portfolio of the Bundesbank. Weber’s applications for the risk assessment are pending in Brussels and in Frankfurt. She says if she’s denied the information, she will seek legal remedies.

Weber also has a lawsuit against Bayer AG to force the company to publish its due diligence report. Her case will be heard on 12 September before the Higher Regional Court of Cologne.

Bayer, which promises "higher standards of transparency", paid $62 billion for Monsanto. A quarter of that is said to have come from equity, from sales of company shares to BASF, which the US Securities and Exchange Commission had demanded, and from the sale of materials manufacturer Covestro. In addition, Bayer had issued new shares through a capital increase and engaged Bank of America, Crédit Suisse, and Haus Rothschild for the remainder.

The Bundesbank’s head, Weidmann, has applied for the position of ECB president. But, according to Weber, having given European taxpayers' money to Monsanto’s shareholders, his chances of getting the top job are falling along with Bayer’s share price.

Menu

Home

Subscriptions

News Archive

News Reviews

GM Book

Resources

Non-GM Successes

GM Myth Makers

GM Myths

GM Quotes

GM Booklet

Contacts

Contact Us

About

Facebook

Twitter

Donations

Content 1999 - 2025 GMWatch.
Web Development By SCS Web Design